123 Risk of dementia related to APOE ε4 and a polygenic risk score 39. McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48(10):1279-83. 40. Durbin R. Efficient haplotype matching and storage using the positional BurrowsWheeler transform (PBWT). Bioinformatics (Oxford, England). 2014;30(9):1266-72. 41. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS genetics. 2013;9(3):e1003348. 42. Cruchaga C, Del-Aguila JL, Saef B, Black K, Fernandez MV, Budde J, et al. Polygenic risk score of sporadic late-onset Alzheimer’s disease reveals a shared architecture with the familial and early-onset forms. Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2018;14(2):205-14. 43. Sabuncu MR, Buckner RL, Smoller JW, Lee PH, Fischl B, Sperling RA. The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cerebral cortex (New York, NY : 1991). 2012;22(11):2653-61. 44. Martiskainen H, Helisalmi S, Viswanathan J, Kurki M, Hall A, Herukka SK, et al. Effects of Alzheimer’s disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach. Journal of Alzheimer’s disease : JAD. 2015;43(2):565-73. 45. Ge T, Sabuncu MR, Smoller JW, Sperling RA, Mormino EC. Dissociable influences of APOE ε4 and polygenic risk of AD dementia on amyloid and cognition. Neurology. 2018;90(18):e1605-e12. 46. Leonenko G, Shoai M, Bellou E, Sims R, Williams J, Hardy J, et al. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition. Ann Neurol. 2019;86(3):427-35. 47. Lacour A, Espinosa A, Louwersheimer E, Heilmann S, Hernández I, Wolfsgruber S, et al. Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer’s disease among subjects with mild cognitive impairment. Molecular Psychiatry. 2017;22(1):153-60. 48. Rodríguez-Rodríguez E, Sánchez-Juan P, Vázquez-Higuera JL, Mateo I, Pozueta A, Berciano J, et al. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease. Journal of Neural Transmission. 2013;120(5):807-12. 49. Ahmad S, Bannister C, van der Lee SJ, Vojinovic D, Adams HHH, Ramirez A, et al. Disentangling the biological pathways involved in early features of Alzheimer’s disease in the Rotterdam Study. Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2018;14(7):848-57. 50. Adams HHH, de Bruijn RFAG, Hofman A, Uitterlinden AG, van Duijn CM, Vernooij MW, et al. Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia. Alzheimer’s & Dementia. 2015;11(11):1277-85. 51. Lopresti BJ, Campbell EM, Yu Z, Anderson SJ, Cohen AD, Minhas DS, et al. Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories. Neurobiology of aging. 2020;94:111-20. 5
RkJQdWJsaXNoZXIy MjY0ODMw